EVOQ Remedies share price
You have to be logged in to add this to Watchlist.- ₹2.61(-4.74%)December 11, 2025 15:44:46 PM IST
- NSE
- BSE
- Vol : 204.00 K (NSE + BSE)Last 20 day avg : 134.40 K
EVOQ Remedies is trading -4.74% lower at Rs 2.61 as compared to its last closing price. EVOQ Remedies has been trading in the price range of 2.74 & 2.61. EVOQ Remedies has given -64.87% in this year & -13.02% in the last 5 days. EVOQ Remedies has TTM P/E ratio 5.56 as compared to the sector P/E of 25.52.The company posted a net profit of 0.05 Crores in its last quarter.Listed peers of EVOQ Remedies include Divi's Laboratories (2.22%), Torrent Pharmaceuticals (0.26%), Cipla (1.53%).The Mutual Fund holding in EVOQ Remedies was at -% in . The MF holding has - from the last quarter. The FII holding in EVOQ Remedies was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 11, 2025, 06:44 PM UTC
- BetaHigh volatility2.32Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.15The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values3.86Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-0.06The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,432.25 | 2.22 | 1,70,923.07 | 78.27 | 11.47 | 0.46 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 3,802.90 | 0.26 | 1,28,663.23 | 66.64 | 16.92 | 0.84 | 17.62 |
| Cipla | Moderately Bearish | 1,512.00 | 1.53 | 1,22,135.00 | 23.33 | 3.94 | 0.85 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,272.95 | 1.75 | 1,06,357.15 | 18.80 | 3.17 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Bullish | 1,806.90 | 1.16 | 4,32,750.00 | 37.94 | 6.04 | 0.88 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-10-10 | Quarterly Results |
| 2025-10-09 | Half Yearly Results |
| 2025-05-06 | Preferential issue of shares |
| 2025-04-29 | Others |
| 2025-04-25 | Preferential issue of shares & Others |
- IndustryBiotechnology & Drugs
- ISININE0JVD01011
- BSE Code543500
- NSE Code
EVOQ Remedies is trading at 2.61 as on Thu Dec 11 2025 10:14:46. This is -4.74% lower as compared to its previous closing price of 2.74.
The market capitalization of EVOQ Remedies is 6.50 Cr as on Thu Dec 11 2025 10:14:46.
The 52 wk high for EVOQ Remedies is 9.28 whereas the 52 wk low is 2.11
EVOQ Remedies can be analyzed on the following key metrics -
- TTM P/E: 5.56
- Sector P/E: 25.52
- Dividend Yield: 0.00%
- D/E ratio: 0.00
EVOQ Remedies reported a net profit of 0.09 Cr in 2025.
EQUITY QUICK LINKS
EVOQ Remedies QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.